Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I clinical trial to evaluate the safety and immunogenicity of a CTL multi-epitiope peptide HIV vaccine formulated with RC529-se, with or without GM-CSF, in healthy, HIV-1 uninfected adult participants
Description
HVTN 056 is a Phase I clinical trial to evaluate the safety and immunogenicity of a CTL multi-epitiope peptide HIV vaccine formulated with RC529-se, with or without GM-CSF.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.